Titan Laboratories


Contract pharmaceutical manufacturer and developer established in 2006. Provides formulation development, scale-up and commercial manufacture of solid and semi-solid dosage forms (pellets, granules, tablets, capsules, creams/ointments). Operates high-capacity GMP-compliant manufacturing lines with multiple international regulatory approvals, analytical/QC services, serialization and packaging lines, dedicated potent-area production, and regulatory dossier support (eCTD/EU CTD) for exports to regulated markets.

Industries

Pharmaceutical Manufacturing

Nr. of Employees

medium (51-250)

Titan Laboratories


Products

Finished-dosage-form portfolio (generics and specialty medicines)

Broad portfolio of finished dosage forms across therapeutic areas (tablets, capsules, pellets, granules, creams/ointments) including immediate- and sustained-release forms, DC granules and MUPS; selected products have EU CTD dossiers and additional pipeline products are scheduled for dossier submission between 2026–2028.


Services

Integrated on-site services from formulation development through scale-up, commercial manufacture, packaging and regulatory support for solid and semi-solid dosage forms.

Laboratory and pilot development for IR/DR/SR/enteric/MUPS and direct compression granules with technology transfer to commercial lines.

On-site QC and analytical testing to support release, stability programs and regulatory submissions (HPLC, dissolution, moisture analysis).

Compilation and maintenance of eCTD/EU CTD dossiers and consultative support for submissions to international regulatory authorities.

Finished-product packaging including blister, alu-alu, bottle and tube lines with 2D matrix printing/verification and anti-tamper integration to support track-and-trace requirements.

Manufacture of potent APIs and controlled substances in dedicated potent-area facilities with regulatory approvals and clearance handling.

Expertise Areas

  • Contract development and manufacturing (CDMO) for solid and semi-solid dosage forms
  • Pellet and granule technologies including MUPS and DC granules
  • Formulation development for IR/DR/SR and enteric systems
  • Scale-up, process development and technology transfer
  • Show More (6)

Key Technologies

  • Fluid-bed coating and drying (top/bottom spray)
  • Extrusion and spheronization
  • High-speed tablet compression (including bi-layer)
  • Capsule filling for pellets, powders and mini-tablets
  • Show More (11)

News & Updates

Recipient of TAB Harmony Award for the years 2020-2021 and 2021-2022.

Recipient of Outstanding Export Award for the years 2014-2015 and 2015-2016.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.